Clinical Trial Update: Mesenchymal Stromal Cells for Acute Graft Versus Host Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating mesenchymal stromal cells for acute graft-versus-host disease. The current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Mesenchymal stromal cells

Snippet

Sponsor: R.P.Herrmann | Conditions: Acute GVH Disease | Phase 2 | Status: UNKNOWN